Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-08-12
1986-04-01
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 16, 514 17, 514 18, 2601125R, A61K 3700, C07C10352
Patent
active
045798400
ABSTRACT:
Methods and peptides for blocking immunogloblin Fc receptors are set forth.
REFERENCES:
patent: 3928306 (1975-12-01), Uchiyama et al.
patent: 3971736 (1976-07-01), Wagner et al.
patent: 4107298 (1978-08-01), Luning
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4250086 (1981-02-01), Heavner
patent: 4308181 (1981-12-01), McGregor
patent: 4309340 (1982-01-01), Sarantakis
patent: 4310456 (1982-01-01), Goldberg
patent: 4311639 (1982-01-01), Ganfield et al.
patent: 4341761 (1982-07-01), Ganfield et al.
patent: 4353822 (1982-10-01), Goldberg
patent: 4369137 (1983-01-01), Heavner
patent: 4374765 (1983-02-01), McGregor
patent: 4377516 (1983-03-01), Goldberg
patent: 4392997 (1983-07-01), Goldberg
patent: 4395404 (1983-07-01), Low et al.
patent: 4415493 (1983-11-01), Weigle et al.
patent: 4426324 (1984-01-01), Merenhofer
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4438029 (1984-03-01), Erickson et al.
Hunninghake et al., Clin Immunol Rev. 1 (3) 337 (1981-1982).
Cochrane et al., Lancet 1,441 (1976).
Hunsicker, J. Exp. Med. 150 413, (1979).
Douvas, Ann. Immunol. Inst. Pasteur, 132C, 307 (1981).
Johnson et al., J. Immunol., 117, 1491, (1975).
Ulcerative colitis (Hibi, et al., Clin. Exp. Immunol., 49, 75 (1982).
Boackle et al., Nature 282, 742 (1979).
Hashimoto's thyroiditis (Calder et al., Clin, Exp. Immunol., 14, 153 (1973).
Prystowksy et al., Biochemistry 20, 6349 (1981).
Gonzalez-Molina et al., J. Clin. Invest., 59, 616 (1977).
Lukas et al., J. Immunol. 127, 2555 (1981).
Merrifield, J. Am. Chem. Soc., 85, 2149-2154 (1963).
Burton et al., Nature 288, 338 (1980).
Barany & Merrifield in The Peptides eds. E. Gross & F. Meinehofer, vol. 2 (Academic Press, 1980) pp. 2 285.
Veretennikova et al., Int. J. Peptide Protein Res. 17, 430 (1981).
Synthesis of a Tetrapeptide by R. B. Merrifield, Journal of American Chemical Society (vol. 85, pp. 2 2154 (1963).
Morgan et al., Proc. Natl. Acad. Sci, USA 79, 5388 (1982).
Ciccimarra et al., Proc. Natl. Acad. Sci. USA 72 208 (1975).
Stanworth Mol. Immunol. 19 1245 (1982).
Hamburger, Science 189, 389 (1975).
Plummer et al., Fed. Proc. 42, 713 (1983).
Hamburger, Immunology 38, 78 (1979).
Biochem, J., 180 665 (1979).
Biochem, J., 181,623 (1979).
Barnett-Foster et al., Mol. Immunol 19 407 (1982).
Barnett-Foster et al., J. Immunol 120, 407 (1978).
Takatsu et al., J. Immunol 114, 1838 (1975).
Dorrington et al., Immunol Rev. 41, 3 (1978).
Perex-Montfort Mol. Immunol 19, 1113 (1982).
Kuehl et al., Science 210, 978 (1980).
Goodwin Clin., Immunol Immunopath 15, 106 (1980).
Stenson et al., Immunol 125, 1 (1980).
Leung et al., J. Immunol 129,1742 (1982).
Klein et al., Immunol 48, 337 (1983).
Goodwin et al., Cancer Immunol Immunother. 8, 3 (1980).
Samuelsson, Science 220, 568 (1983).
Weiss et al., J. Immunol 129, 309 (1982).
Perex et al., Textbook Rheumatogoly, vol. 1, W. B. Saunders, Philadelphia, 1981, pp. 179-194.
Dreisn et al., N. Engl. J. Med. 298, 358 (1978).
Lawrence et al., N. Engl. J. Med. 302,1187 (1980).
Holdsworth, J. Immunol 130, 735 (1983).
Striker, J. Exp. Med. 149, 127 (1979).
Kumar in Pathologic Basis of Disease, eds. S. L. Robbins & R. S. Cotran (W. B. Saunders; Philadelphia, 1979), p. 304.
Melwicz et al., Clin. Exp. Immunol., 49, 364 (1982).
Spiegelberg, et al., 42, 124 (1983).
Scott et al., Fed. Proc. 42, 129 (1983).
McMillan, N. Engl. J. Med. 304, 1135 (1981).
Fehr et al., (N. Engl. J. Med., 306, 1254 (1982).
Imbach et al., (Lancet, Jun. 6, 1981, p. 1228).
Oberbarnscheidtet et al., Immunol., 35, 151 (1978).
Kolsch et al., Immunol Rev. 49, 61 (1980).
Fridman et al., Immunol Rev. 56, 51 (1981).
Bich-Thuy, J. Immunol. 129, 150 (1982).
Smolen et al., J. Immunol. 129, 10150 (1982).
Goeken et al., Hum. Immunol. 6, 79 (1983).
Kabelitz et al., Eur. J. Immunol. 12, 687 (1982).
Sakane et al., Proc. Natl. Acad. Sci. U.S.A. 75, 3464 (1978).
Miyasaka et al., J. Clin. Invest., 66, 928 (1980).
James et al., J. Clin. Invest., 66, 1305 (1980).
Hodgkin's Lymphoma (Engleman, et al., J. Clin. Invest., 66 149 (1980).
Smith et al., J. Natl. Cancer Inst., 58, 579 (1977).
Immunetech Pharmaceuticals
Phillips Delbert R.
LandOfFree
Method of blocking immune complex binding to immunoglobulin Fc r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of blocking immune complex binding to immunoglobulin Fc r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of blocking immune complex binding to immunoglobulin Fc r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1084575